UNSPSC 51361507: Chloralodol or chlorhexadol

This classification denotes a hypnotic with the molecular formula C8H15Cl3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W8RD4N93R2, chemically known as 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)pentan-2-ol but generally known as chloralodol, which bears US NIH Compound Identifier 19094. European Medicines Agency schedules chloralodol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07465MIG. SMILES: CC(CC(C)(C)O)OC(C(Cl)(Cl)Cl)O.

UNSPSC 51361507 Chloralodol or chlorhexadol is a Commodity code that in recent state and local procurement activity has been used to tag purchases of pharmaceutical emergency-response products and drug-deactivation systems rather than the specific chemical compound the code nominally describes. Seminole County, Florida's recent IFB for naloxone and drug deactivation systems illustrates the practical scope: counties are acquiring these products to support community health and opioid-response initiatives, with standing orders and multi-year supply contracts. The issuing body in the single recent posted opportunity is a county government, though the code's actual application across state and local jurisdictions is not fully visible in current available records.

Seminole County, Florida represents the geographic activity visible under this code. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, full vendor responsibility for shipping and delivery, and potential FEMA funding with associated federal compliance requirements. Bidders must satisfy E-Verify, drug-free workplace certification, and insurance coverage mandates including workers' compensation and professional liability. No explicit set-aside designations were noted in the posting.